Combined oral contraceptive use and venous thrornboernbolism

References

• Jordan W. M. Pulmonary embolism. Lancet 1961; 2: 1146–7
   Google Scholar
• Tyler E. T. Oral contraception and venous thrombosis. J. Am. Med. Assoc. 1963; 185: 131–2
   Google Scholar
• Ad Hoc Advisory Committee for the Evaluation of a Possible Etiologic Relation with Thromboembolic Conditions. FDA Report on Enovid. J. Am. Med. Assoc. Sept. 7, 1963; 185: 776
   Google Scholar
• Cahal D. A. Safety of oral contraceptives. Br. Med. J. 1965; 4: 1180
   Google Scholar
• WHO Scientific Group. Clinical aspects of oral gestogens. Report of a WHO Scientific Group. World Health Organization Technical Report Series 1966, WHO, Geneva 1966, No. 326
   Google Scholar
• Records Unit and Research Advisory Service of the Royal College of General Practitioners. Oral contraception and thromboembolic disease. J. Coll. Gen. Practit. 1967; 13: 267–79
   Google Scholar
• Innian W. H.W., Vessey M. P. Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age. Br. Men. J. 1968; 2: 193–9
   Google Scholar
• Vessey M. P., Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. Br. Med, J. 1968; 2: 199–205
   PubMed Web of Science ®Google Scholar
• Vessey M. P., Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br. Med. J. 1969; 2: 651–7
   PubMed Web of Science ®Google Scholar
• Sartwell P. E., Masi A. T., Arthes F. G., Greene G. R., Smith H. E. Thromboembolism and oral contraceptives: an epidemiologic case-control study. Am. J. Epidemiol. 1969; 90: 365–80
   PubMed Web of Science ®Google Scholar
• Boston Collaborative Drug Surveillance Programme. Oral contraceptives and venous thromboembolic disease, surgically confirmed gall-bladder disease, and breast tumours. Lancet 1973; 1: 1399–404
   PubMed Web of Science ®Google Scholar
• Stolley P. D., Tonascia J. A., Tockman M. S., Sartwell P. E., Rutledge A. H., Jacobs M. P. Thrombosis with low-estrogen oral contraceptives. Am. J. Epidemiol. 1975; 102: 197–208
   PubMed Web of Science ®Google Scholar
• Maguire M. G., Tonascia J., Sartwell P. E., Stolley P. D., Tockman D. S. Increased risk of thrombosis due to oral contraceptives: a further report. Am. J. Epidemiol. 1979; 110: 188–95
   PubMed Web of Science ®Google Scholar
• Helmrich S. P., Rosenberg L., Kaufman D. W., Strom B., Shapiro S. Venous thromboembolism in relation to oral contraceptive use. Obstet. Cynecol. 1987; 69: 91–5
   Google Scholar
• Vandenbroucke J. P., Koster T., Briët E., Reitsma P. H., Bertina R. M., Rosendaal F. R. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453–7
   PubMed Web of Science ®Google Scholar
• Thorogood M., Mann J., Murphy M., Vessey M. Risk factors for fatal venous thromboembolism in young women: a case-control study. Int. J. Epidemiol. 1992; 21: 48–52
   PubMed Web of Science ®Google Scholar
• Royal College of General Practitioners' Oral Contraception Study. Oral contraceptives, venous thrombosis, and varicose veins. J. R. Coll. Gen. Practit. 1978; 28: 393–9
   PubMedGoogle Scholar
• Petitti D. B., Winegerd J., Pellegrin F., Ramcharan S. Oral contraceptives, smoking, and other factors in relation to risk of venous thromboembolic disease. Am. J. Epidemiol. 1978; 108: 480–5
   PubMed Web of Science ®Google Scholar
• Vessey M., Mant D., Smith A., Yeates D. Oral contraceptives and venous thromboembolism: findings in a large prospective study. Br. Med. J. 1986; 292: 526
   PubMed Web of Science ®Google Scholar
• Porter J. B., Hunter J. R., Danielson D. A., Jick H., Stergachis A. Oral contraceptives and nonfatal vascular disease — recent experience. Obstet. Gynecol. 1982; 59: 299–302
   PubMed Web of Science ®Google Scholar
• Porter J. B., Hunter J. R., Jick H., Stergachis A. Oral contraceptives and nonfatal vascular disease. Obstet. Gynecol. 1985; 66: 1–4
   PubMed Web of Science ®Google Scholar
• Farmer R. T., Preston T. D. The risk of venous thromboembolism associated with low oestrogen oral contraceptives. J. Obstet. Gynaecol. 1995; 15: 195–200
   Google Scholar
• Gerstman B. B., Piper J. M., Tomita D. K., Ferguson W. J., Stadel B. V., Lundin F. E. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am. J. Epidemiol. 1991; 133: 32–7
   PubMed Web of Science ®Google Scholar
• Glass R., Johnson B., Vessey M. Accuracy of recall of histories of oral contraceptive use. Br. J. Prev. Soc. Med. 1974; 28: 273–5
   PubMedGoogle Scholar
• Stolley P. D., Tonascia J. A., Sartwell P. E., Tockman M. S., Tonascia S., Rutledge A., Schinner R. Agreement rates between oral contraceptive users and prescribers in relation to drug use histories. Am. J. Epidemiol. 1978; 107: 226–35
   PubMed Web of Science ®Google Scholar
• Sartwell P. E. Oral contraceptives and thromboembolism: a further report. Am. J. Epidemiol. 1971; 94: 192–201
   Google Scholar
• Lawson D. H., Davidson J. F., Jick H. Oral contraceptive use and venous thromboembolism: absence of an effect of smoking. Br. Med. J. 1977; 2: 729–30
   Google Scholar
• Jick H., Slone D., Westerholm B., Inman W. H. W., Vessey M. P., Shapiro S., Lewis G. P., Worcester J. Venous thromboembolic disease and ABO blood type. Lancet 1969; 1: 539–42
   PubMed Web of Science ®Google Scholar
• Böttiger L. E., Wersterholm B. Oral contraceptives and thromboembolic disease. Acta Med. Scand. 1971; 190: 455–63
   PubMedGoogle Scholar
• Thorogood M., Vessey M. P. Trends in use of oral contraceptives in Britain. Br. J. Fam. Plann. 1990; 16: 41–53
   Google Scholar
• Inman W. H. W., Vessey M. P., Westerholm B., Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br. Med. J. 1970; 2: 203–9
   PubMed Web of Science ®Google Scholar
• Böttiger L. E., Boman G., Eklund G., Westerholm B. Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content. Lancet 1980; 1: 1097–101
   PubMed Web of Science ®Google Scholar
• Meade T. W., Greenberg G., Thompson S. G. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-μg oestrogen preparations. Br. Med. J. 1980; 2: 1157–61
   Google Scholar
• Royal College of General Practitioners' Oral Contraception Study. Further analyses of mortality in oral contraceptive users. Lancet 1981; 1: 541–6
   Google Scholar
• Vessey M. P., Villiard-Mackintosh L., McPherson K., Yeates D. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study. Br. Med. J. 1989; 299: 1487–91
   PubMed Web of Science ®Google Scholar